IPO · CORONA

Corona Remedies IPO listing gain & performance.

Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.

· data for the trading session of Wed 18 Nov 2026

Issue price₹1,062.00₹1008 to ₹1062
Listing gain+38.4%at the opening price
Since the IPO+112.4%₹2,256.20 on 18 Nov
Subscribed137×times in total

Corona Remedies IPO in brief

Written from NSE’s data, as of 18 Nov 2026.

Corona Remedies came to the market at ₹1,062.00 a share (price band ₹1008 to ₹1062), with bidding open from 8 December to 10 December 2025. It listed on NSE on Monday, 15 December 2025, opening at ₹1,470.00, a gain of 38.4% on the issue price, and closed the first day +35.4% from the issue price after trading between +33.1% and +41.0%. 33% of the first day’s traded shares were taken for delivery.

The issue was subscribed 137× in total, institutions (QIB) 279×, HNIs (NII) 209×, retail investors 28.7×. Across the 91 IPOs subscribed 50× or more, the median listing gain was +26.6%.

Its listing gain beat 88% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 6 months after listing it was +73.9% from the issue price and +28.4% from the first-day close, while NIFTY 50 moved -7.4% over the same days. Its highest price so far was 156% above the issue price (9 Nov 2026) and its lowest 26% above it (23 Dec 2025); it closed below the issue price on 0% of the days since listing.

Share price since listing

Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.

IPO ₹1,06215 Dec 202518 Nov 2026₹2,256

Subscription

Times subscribed by investor group, NSE + BSE bids as reported by NSE.

Qualified institutions (QIB)279×
Non-institutional (NII / HNI)209×
NII, bids above ₹10 lakh234×
NII, ₹2–10 lakh159×
Retail investors28.7×
Employees14.7×
Total137×

For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.

Listing day

Monday 15 December 2025.

Open+38.4%vs issue price
High / low+41% / +33%vs issue price
Close+35.4%vs issue price
Delivery33%₹1,879 Cr traded

Returns after listing

Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.

After listingFrom issue priceFrom first-day closeNIFTY 50Median IPO (from issue)
1 week22 Dec 2025+27.5%-5.8%+0.6%+8.0%
1 month14 Jan 2026+38.9%+2.6%-1.4%+9.4%
3 months17 Mar 2026+47.0%+8.5%-9.4%+10.3%
6 months22 Jun 2026+73.9%+28.4%-7.4%+8.0%

IPO details

From NSE’s issue page.

Company
Corona Remedies
NSE symbol
CORONA
Board
Main board
Industry
Pharmaceuticals
Bidding
8 Dec – 10 Dec 2025
Price band
₹1008 to ₹1062
Issue price
₹1,062.00
Issue size
Initial Public Offer of Offer for Sale aggregating upto Rs. 6553.71 million (including Eligible Employee Reservation Portion aggregating upto Rs. 58.50 million and Anchor investors portion of 18,34,804 Equity Shares)
Bid lot
14 Equity Shares and in multiples thereof
Listing date
15 December 2025
ISIN
INE02ZQ01018

Corona Remedies share price, delivery & results →How all IPOs did after listing →IPO calendar →

Questions

What was the listing gain of the Corona Remedies IPO?
Corona Remedies listed on 15 December 2025 and opened +38.4% against its issue price of ₹1,062.00; it closed the first day +35.4% from the issue price.
What is the Corona Remedies share price now against the IPO price?
At the close of 18 November 2026, Corona Remedies was at ₹2,256.20, +112.4% from the IPO price of ₹1,062.00.
How many times was the Corona Remedies IPO subscribed?
Corona Remedies’s IPO was subscribed 137× in total; QIB 279×; NII 209×; retail 28.7× (NSE + BSE bids, as reported by NSE).
When was the Corona Remedies IPO open?
Bidding ran from 8 December to 10 December 2025 at a price band of ₹1008 to ₹1062; the shares listed on 15 December 2025.

From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.